Epidemiologic and Molecular Characterization of Human Immunodeficiency Virus Type 1 in Southern Brazil

Journal of Acquired Immune Deficiency Syndromes

Volumn 34, Issue 5, 2003, Pages 520-526

  Soares, Esmeralda A J M ^a   Santos, Rodrigo P ^b   Pellegrini, José Augusto ^b   Sprinz, Eduardo ^b   Tanuri, Amilcar ^a   Soares, Marcelo A ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

AIDS epidemiology; Brazil; Drug resistance; HIV 1; Subtype C

Indexed keywords

ANTIRETROVIRUS AGENT; COMPLEMENTARY DNA; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAZIL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE OF ONSET; BRAZIL; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, VIRAL;

EID: 0345490967     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200312150-00012     Document Type: Article

References (37)

1. Osmanov S, Pattou C, Walker N, et al. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr. 2002;29:184-190.
2. McCormack GP, Glynn JR, Crampin AC, et al. Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi. J Virol. 2002;76:12890-12899.
3. Robbins KE, Kostrikis LG, Brown TM, et al. Genetic analysis of human immunodeficiency virus type 1 strains in Kenya: a comparison using phylogenetic analysis and a combinatorial melting assay. AIDS Res Hum Retroviruses. 1999;15:329-335.
4. Snoeck J, Van Dooren S, Van Laethem K, et al. Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999. Virus Res. 2002;85:95-107.
5. Balotta C, Facchi G, Violin M, et al. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr. 2001;27:499-505.
6. Puchhammer-Stockl E, Kunz C, Faatz E, et al. Introduction of HIV-1 subtypes C, E and A into Austria. Clin Diagn Virol. 1999;9:25-28.
7. Sonnerborg A, Durdevic S, Giesecke J, et al. Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993. AIDS Res Hum Retroviruse. 1997;13:343-345.
8. Novitsky V, Smith UR, Gilbert P, et al. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol. 2002;76:5435-5451.
9. Gaschen B, Taylor J, Yusim K, et al. Diversity considerations in HIV-1 vaccine selection. Science. 2002;296:2354-2360.
10. Cao H, Mani I, Vincent R, et al. Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda. J Infect Dis. 2000;182:1350-1356.
11. Dorrell L, Dong T, Ogg GS, et al. Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa. J Virol. 1999;73:1708-1714.
12. Velazquez-Campoy A, Vega S, Freire E. Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes. Biochemistry (Mosc). 2002;41:8613-8619.
13. Velazquez-Campoy A, Todd MJ, Vega S, et al. Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes. Proc Natl Acad Sci USA. 2001;98:6062-6067.
14. Holguin A, Alvarez A, Soriano V. High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid. AIDS. 2002;16:1163-1170.
15. Bongertz V, Bou-Habib DC, Brigido LF, et al. HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization. J Acquir Immune Defic Syndr. 2000;23: 184-193.
16. Couto-Fernandez JC, Morgado MG, Bongertz V, et al. HIV-1 subtyping in Salvador, Bahia, Brazil: a city with African sociodemographic characteristics. J Acquir Immune Defic Syndr. 2000;22:288-293.
17. Cornelissen M, Kampinga G, Zorgdrager F, et al. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization. J Virol. 1996;70:8209-8212.
18. Brindeiro RM, Diaz RS, Sabino EC, et al. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): results from the first national survey. AIDS. 2003;17:1063-1069.
19. Dumans AT, Soares MA, Pieniazek D, et al. Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. Antimicrob Agents Chemother. 2002;46:3075-3079.
20. Turchi MD, Diaz RS, Martelli CM, et al. Genetic diversity and HIV-1 incidence estimation among cocaine users in Sao Paulo, Brazil. J Acquir Immune Defic Syndr. 2002;30:527-532.
21. Soares MA, Oliveira T, Brindeiro RM, et al. A specific subtype C of human immunodeficiency virus type I circulates in Brazil. AIDS. 2003; 17: 11-21.
22. Stuyver L, Wyseur A, Rombout A, et al. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother. 1997; 41:284-291.
23. Korber BT, Learn G, Mullins JI, et al. Protecting HIV databases. Nature. 1995;378:242-244.
24. Durand P, Canard L, Mornon JP. Visual BLAST and visual FASTA: graphic workbenches for interactive analysis of full BLAST and FASTA outputs under Microsoft Windows 95/NT. Comput Appl Biosci. 1997; 13: 407-413.
25. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673-4680.
26. Smith SW, Overbeek CR, Woese W, et al. The Genetic Data Environment: an expandable GUI for multiple sequence analysis. Comput Appl Biosci. 1994;10:671-675.
27. Swofford D. PAUP 4.0: Phylogenetic Analysis Using Parsimony (and Other Methods). Version 4.0b2a. Sunderland, MA: Sinauer Associates; 1999.
28. Gurtler LG, Hauser PH, Eberle J, et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol. 1994;68: 1581-1585.
29. Kantor R, Machekano R, Gonzales MJ, et al. Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs. Nucleic Acids Res. 2001;29:296-299.
30. D'Aquila RT, Shapiro JM, Brun-Vézinet F, et al. Drug resistance mutations in HIV-1. Topics HIV Med. 2002;10:21-25.
31. Ramos A, Tanuri A, Schechter M, et al. Dual and recombinant infections: an integral part of the HIV-1 epidemic in Brazil. Emerg Infect Dis. 1999; 5:65-74.
32. Tanuri A, Swanson P, Devare S, et al. HIV-1 subtypes among blood donors from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 1999;20: 60-66.
33. Martinez AMB, Mendoza-Sassi G, Mendonça-Signorini V, et al. Prevalence of subtypes B and C and correlation to survival in HIV-1-positive patients followed at UH in the city of Rio Grande, RS. Braz J Infect Dis. 2001;5(Suppl):S22.
34. Caride E, Hertogs K, Larder B, et al. Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. Virus Genes. 2001;23:193-202.
35. Grossman Z, Vardinon N, Chemtob D, et al. Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B. AIDS. 2001;15:1453-1460.
36. Caride E, Brindeiro RM, Hertogs K, et al. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART. Virology. 2000;275:107-115.
37. Pérez-Alvarez L, Cuevas MT, Villahermosa ML, et al. Prevalence of drug resistance mutations in B, non-B subtypes, and recombinant forms of human immunodeficiency virus type I in infected individuals in Spain (Galicia). J Hum Virol. 2001;4:35-38.